Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
87.40    2.10 (2.46%)
Bid:
87.00
Ask:
88.90
Spread: 1.90 (2.184%)
Market Cap: £367.39m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

AGM Trading Statement

23 Nov 2023 07:00

RNS Number : 3941U
PZ CUSSONS PLC
23 November 2023
 

 

23 November 2023

AGM TRADING STATEMENT

 

Ahead of its Annual General Meeting which takes place today, PZ Cussons issues the following update on current trading and developments in Nigeria.

Trading update

 

Trading has continued to be in line with expectations and consistent with the FY24 outlook provided at our FY23 full year results on 26 September.

 

The Group expects to report low-single-digit like-for-like revenue growth for H1 FY24. This reflects strong growth in Nigeria and ANZ offset by a decline in Indonesia. Our Europe and Americas business is stable overall, with significantly-improving momentum in our UK washing and bathing brands offset by a decline in our Beauty business.

 

We expect to deliver a robust year-on-year operating margin improvement in H1 FY24 and both revenue growth and operating margin to improve in H2 compared to H1. Further guidance will be provided at our interim results, including the FY24 effective tax rate, non-controlling interest and net interest charge, each of which will be largely driven by trading in Nigeria and other developments there.

 

Nigeria update

 

Building on the strategic progress already made in Nigeria since the loss-making position in FY20, trading in the first half of the year has continued to be strong. The majority of our brands have held or gained market share and we have seen no material change in our volume trends in recent weeks[1]. We expect to achieve an improvement in both gross and operating profit margins in the first half of the year, despite very high levels of inflation.

 

As noted in September at our full year results, the lack of availability of US Dollars in Nigeria has created significant challenges for the day-to-day funding of the Nigerian business and the repatriation of cash to the Group's holding companies. This issue was exacerbated in June 2023, following the new government's liberalisation of the FX regime and resulting devaluation of the Naira. We have since accelerated both our operational and corporate plans, enabling us to mitigate these risks so far in FY24. More broadly, in recent weeks, FX market liquidity has shown tentative signs of improvement.

 

As a result:

 

· Our business in Nigeria expects to be able to continue to meet its needs for the foreign currency required for day-to-day operations, which will eliminate the need for further lending from the Group's holding companies.

· We have also started to repatriate cash in recent weeks which, combined with underlying strong free cash flow, is expected to result in a c. £20 million reduction in Group gross debt since 31 May 2023[2].

· Based on prevailing rates, the current Naira cash balance is equivalent to c. £80-100 million[3]. Assuming current market conditions persist, the Group aims to repatriate a further £30-50 million of cash by the end of FY24.

· The proposed transaction to de-list and buy out the minority shareholdings of PZ Cussons Nigeria plc is progressing as planned. The Group welcomes the recent recommendation of the Board of PZ Cussons Nigeria to minority shareholders to accept a revised offer of ?23 per share[4] and expects the transaction to complete before 31 May 2024. The purchase of the minority shareholdings will be funded from our local Naira cash balance.

· We therefore expect only a minimal surplus cash position remaining in Nigeria, beyond that required for trading, by the end of this financial year.

 

Additional sensitivities and implications of the devaluation in the Naira, which will impact the H1 FY24 reported results, were set out in our Trading Statement on 27 June 2023.

 

***

 

The Group will report its FY24 interim results on Wednesday 7 February 2024.

 

For further information please contact:

Investors

Simon Whittington - IR and Corporate Development Director +44 (0) 77 1137 2928

 

Media

Headland PZCussons@headlandconsultancy.com +44 (0) 20 3805 4822

Susanna Voyle, Stephen Malthouse, Charlie Twigg

 

Notes to Editors

 

About PZ Cussons

 

PZ Cussons is a FTSE250 listed consumer goods business headquartered in Manchester, UK. We employ nearly 3,000 people across our operations in Europe, North America, Asia-Pacific and Africa. Since our founding in 1884, we have been creating products to delight, care for and nourish consumers. Across our core categories of Hygiene, Baby and Beauty, our trusted and well-loved brands include Carex, Childs Farm, Cussons Baby, Imperial Leather, Morning Fresh, Original Source, Premier, Sanctuary Spa and St. Tropez. Sustainability and the wellbeing of our employees and communities everywhere are at the heart of our business model and strategy and captured by our purpose: For everyone, for life, for good.


[1] Source: market share for the Nigeria Hygiene, Baby and Beauty business based on the 12 months to September 2023 (Nielsen Retail Audit)

[2] As at the end of November, after the payment of the FY23 final dividend

[3] £80-100 million based upon NGN/USD rates of 1,000 and 1,200 which is the range within which US Dollars have been sourced during October and November and compares to a current official rate of approximately 800

[4] Equivalent to £25 million based on USD/GBP rate of 1.24 and an assumed NGN/USD rate of 800 which is the approximate current official rate

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTLLLLLXFLZFBD
Date   Source Headline
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding
21st Nov 20245:03 pmRNSResult of AGM
21st Nov 20247:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.